Oral diagnosis of Behcet disease in an eleven-year old girl and the non-surgical treatment of her gingival overgrowth caused by Cyclosporine

A case of an eleven-year old girl with Behcet disease is presented. Non-surgical treatment of gingival overgrowth caused by the use of Cyclosporine was successfully treated. This case emphasizes the need for cooperation between the medical and dental professionals and the responsibility of dental profes-sionals to lead the diagnosis of systemic diseases like Behcet.

1. Celenligil-Nazliel H, Kansu E, Ebersole JL. Periodontal findings and systemic antibody responses to oral microorganisms in Behcet’s disease. J Periodontol 70: 1449-1456, 1999.

2. Kontogiannis V, Powell RJ. Behcet’s disease. Postgrad Med J 76: 629- 637, 2000.

3. Aoki T, Tanaka T, Akifuji Y, Ueki J, Nakamura I., Nemoto R, Tio K. Beneficial effects of interferon-alpha in a case with Behcet’s disease. Intern Med 39: 667-9, 2000.

4. Uziel Y, Lazarov A, Cordoba M, Wolach B. Paediatric Behcet disease manifested as recurrent myositis: from an incomplete to a full-blown form. Eur J Pediatr 159: 507-8, 2000.

5. Schor NF. Neurology of systemic autoimmune disorders: a pedi-atric perspective. Seminar Pediatr Neurol 7: 108-17, 2000.

6. Yazici H, Yurdakul S, Hamuryudan V. Behcet disease. Curr Opin Rheumatol 13: 18-22, 2001.

7. Eldem B, Onur C, Ozen S. Clinical features of pediatric Behcet’s disease. J Pediatr Ophtalmol Strabismus 35: 159-161, 1998.

8. Mogulkoc N, Burges MI, Bishop PW. Intracardiac thrombus forma-tion in Behcet’s disease a systematic review. Chest 118: 479-87, 2000.

9. Gonzalez-Gay MA, Garcia-Porrua C, Branas F, Lopez-Lazaro L, Olivieri I. Epidemiologic and clinical aspects of Behcet’s disease in a defined area of Northwestern Spain. J Rheumatol 27: 703-707, 2000.

10. Sakane T, Takeno M. Current therapy in Bechcet’s disease. Skin Therapy 5: 3-5, 2000.

11. Saito M, Miyagawa I. Bladder dysfunction due to Behcet’s dis-ease. Urol Int 65: 40-2, 2000.

12. Gunen H, Evereklioglu C, Kosar F, Er H, Kizkin O. Thoracic involvement in Behcet’s disease and its correlation with multiple parameters. Lung 178: 161-70, 2000.

13. Cacoub P, Sbai A, Wechser B, Brocheriou I, Braesco J, Kieffer E, Piette JC. Vascular manifestations of Behcet’s syndrome associ-ated with solitary ulcerations and resolved with immunosuppres-sants. Rev Med Interne 21: 353-7, 2000.

14. Kim YC, Bang D, Lee S, Lee KH. The effect of herpesvirus infec-tion on the expression of cell adhesion molecules on cultured human dermal microvascular endothelial cells. J Dermatol Sci 24: 38-47, 2000.

15. Kim JS, Lim SH, Choi IJ, Moon H, Jung HC, Song IS, Kim CY. Pre-diction of the clinical course of Behcet’s colitis according to macro-scopic classification by colonoscopy. Endoscopy 32: 635-40, 2000.

16. Demirer S, Sengul N, Yerdel MA, Tuzuner A, Ulus AT, Gurler A, Bergqvist D, Siegbahn A, Karacagil S. Haemostasis in patients with Behcet’s disease. Eur J Vasc Endovasc Surg 19: 570-4, 2000.

17. Misgav M, Goldberg Y, Zeltser D, Eldor A, Berliner AS. Fatal pulmonary artery thrombosis in a patient with Behcet’s disease, activated protein C resitance and hypergomocystinemia. Blood Coagul Fibrinolysis pp 421-3, 2000.

18. Peuckman V, Fisch M, Bruera E. Potential novel uses for thalido-mide. Drugs 60: 273-92, 2000.

19. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the treat-ment of posterior uveitis refractory to cyclosporine. Ophthal-mology 106: 723-8, 1999.

20. Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H. Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy. Ophthalmology 106: 586-9, 1999.

21. Mariotti AJ. Gingival diseases. In: Bimstein E, Needleman HL, Karimbux N, Van Dyke (eds): Periodontal health and diseases. Children, Adolescents and Young Adults. London, Martin Dunitz Ltd., pp 31-48, 2001.

22. Millodot M. Dictionary of optometry and visual science, 4th edi-tion. Butterwirth-Heinemann, Oxford, Reed Educational and Publishing Ltd., p 280, 1997.

23. Bimstein E, Sela MN, Shapira L. Clinical and microbial consid-erations for the treatment of an extended kindred with 7 cases of prepubertal periodontitis: a 2-year follow-up. Ped Dent 19: 396-403, 1997.

24. Hernandez G, Arriba L, Lucas M, Andres A. Reduction of severe gingival overgrowth in a kidney transplant patient be replacing cyclosporin A with tacrolimus. J Periodontol 71: 1630-1636, 2000.

25. Thorp M, DeMattos A, Bennett W, Barry J, Norman D. The effect of conversion from cyclosporine to tacrolimus on gingival hyper-plasia, hirsutism and cholesterol. Transplantation 69: 1210-1220, 2000.

26. James JA, Boomer S, Maxwell AP, Hull PS, Short CD, Campbell B, Johnson RW, Irwin CR, Marley JJ, Spratt H, Linden GJ. Reduction in gingival overgrowth associated with conversion from cyclosporine A to tacrolimus. J Clin Periodontol 27: 144-148, 2000.

27. Page RC, Sims TJ, Delima AJ, Bimstein E, Needleman HL, Van Dyke TE. The relationship between periodontitis and systemic diseases and conditions in children, adolescents and young adults. In: Bimstein E, Needleman HL, Karimbux N, Van Dyke (eds): Periodontal Health and Diseases. Children, Adolescents and Young Adults. London, Martin Dunitz Ltd., pp 108-143, 2001.

28. Gul A, Inanc M, Ocal L, Aral O, Konice M. Familial aggregation of Behcet’s disease in Turkey. Ann Rheum Dis 59: 622-5, 2000.

29. Sgan-Cohen HD. Promotion of gingival and periodontal health from childhood. In: Bimstein E, Needleman HL, Karimbux N, Van Dyke (eds): Periodontal Health and Diseases. Children, Adolescents and Young Adults. London, Martin Dunitz Ltd., pp 208- 225, 2001.